Corrigendum to "Trypanosoma cruzi: Effect of benznidazole therapy combined with the iron chelator desferrioxamine in infected mice" [Exp. Parasitol. 120 (2008) 314-319] (DOI:10.1016/j.exppara.2008.08.002);Trypanosoma cruzi: Effect of benznidazole therapy combined with the iron chelator desferrioxamine in infected mice

Experimental Parasitology

Volumn 120, Issue 4, 2008, Pages 314-319

  Francisco, Amanda Fortes ^a   de Abreu Vieira, Paula Melo ^a   Arantes, Jerusa Marilda ^a   Pedrosa, Maria Lúcia ^a   Martins, Helen Rodrigues ^a   Silva, Maisa ^a   Veloso, Vanja Maria ^a   de Lana, Marta ^a,b   Bahia, Maria Terezinha ^a,b   Tafuri, Washington Luiz ^a   Carneiro, Cláudia Martins ^a,b  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Analysis of variance (ANOVA); benznidazole (BZ); Chagas' disease (CD); Days post infection (dpi); Deoxyribonucleic acid (DNA); desferrioxamine (DFO); Ethylenediamine tetraacetic acid (EDTA); Intraperitoneal (ip); Liver infusion tryptose (LIT); Polymerase chain reaction (PCR); Reactive oxygen species (ROS); Trypanosoma cruzi

Indexed keywords

BENZNIDAZOLE; DEFEROXAMINE; DEFEROXAMINE MESYLATE; HEMOGLOBIN; IRON;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; MALE; MORTALITY; MOUSE; NONHUMAN; PARASITEMIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTOZOAL INFECTION; TRYPANOSOMA CRUZI;

ANIMALIA; MUS; TRYPANOSOMA CRUZI;

EID: 55149099171     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2008.12.007     Document Type: Erratum

References (45)

1. Arantes J.M., Pedrosa M.L., Martins H.R., Veloso V.M., de Lana M., Bahia M.T., Tafuri W.L., and Carneiro C.M. Trypanosoma cruzi: treatment with the iron chelator desferrioxamine reduces parasitemia and mortality in experimentally infected mice. Experimental Parasitology 117 (2007) 43-50
2. Ávila H.A., Sigman D.S., Cohen L.M., Millikan R.C., and Simpson L. Polymerase chain reaction amplification of Trypanosoma cruzi kinetoplast minicircle DNA isolated from whole blood lysates: diagnosis of chronic Chagas disease. Molecular and Biochemical Parasitology 48 (1991) 211-222
3. Blakley B.R., and Hamilton D.L. The effect of iron deficiency on the immune response in mice. Drug Nutrient Interactions 5 (1988) 249-255
4. Brener Z. Therapeutic activity and criterion of cure in mice experimentally infected with Trypanosoma cruzi. Revista do Instituto de Medicina Tropical de São Paulo 4 (1962) 389-396
5. Camargo E.P. Growth and differentiation in Trypanosoma cruzi. I. Origin of metacyclic trypanosomes in liquid media. Revista do Instituto de Medicina Tropical de São Paulo 12 (1964) 93-100
6. Cardoso J.E., and Brener Z. Hematological changes in mice experimentally infected with Trypanosoma cruzi. Memórias do Instituto Oswaldo Cruz 75 (1980) 97-104
7. Clark I.A., and Hunt N.H. Evidence for reactive oxygen intermediates causing hemolysis and parasite death in malaria. Infection and Immunity 39 (1983) 1-6
8. Coura J.R., and de Castro S.L. A critical review on Chagas disease chemotherapy. Memórias do Instituto Oswaldo Cruz 97 (2002) 3-24
9. Crichton R.R., and Ward R.J. Structure and molecular biology of iron binding-proteins and the regulation of free iron pools. In: Lauffer R.B. (Ed). Iron and Human Diseases (1992), CRC Press, Boca Raton 23-75
10. De Souza A.P., Olivieri B.P., De Castro S.L., and Araújo-Jorge T.C. Enzymatic markers of heart lesion in mice infected with Trypanosoma cruzi and submitted to benznidazole chemotherapy. Parasitology Research 86 (2000) 800-808
11. Dhur A., Galan P., and Hercberg S. Iron status, immune capacity and resistance to infections. Comparative Biochemistry and Physiology 94 (1989) 11-19
12. Docampo R. Sensitivity of parasites to free radical damage by antiparasitic drugs. Chemico-biological Interactions 73 (1990) 1-27
13. Esievo K.A., Saror D.I., Ilemobade A.A., and Hallaway M.H. Variation in erythrocyte and free sialic acid serum concentrations during experimental Trypanosoma vivax infection in cattle. Research in Veterinary Science 32 (1982) 1-15
14. Filardi L.S., and Brener Z. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Transactions of the Royal Society of Tropical Medicine and Hygiene 81 (1987) 755-759
15. Galan P., Davila M., Mekki N., and Hereberg S. Iron deficiency, inflammatory processes and humoral immunity in children. International Journal of Vitamin and Nutrition Research 58 (1988) 225-230
16. Galvão L., Nunes R., Cançado J.R., Brener Z., and Krettli A. Lytic antibodies titer as a means of assessing cure after treatment of Chagas' disease: a 10 year follow-up study. Transactions of the Royal Society of Tropical Medicine and Hygiene 87 (1993) 220-223
17. Gomes M.L., Macedo A.M., Vago A.R., Pena S.D., Galvão L.M., and Chiari E. Trypanosoma cruzi: optimization of polymerase chain reaction for detection in human blood. Experimental Parasitology 88 (1998) 28-33
18. In: Henry R.J., Winkelman J.W., and Cannon D.C. (Eds). Clinical Chemistry-Principles and Techniques. second ed. (1974), Harper & Row, New York
19. Hernández S.M., Sánchez M.S., and Schwarcz de Tarlovsky M.N. Polyamines as a defence mechanism against lipoperoxidation in Trypanosoma cruzi. Acta Tropica 98 (2006) 94-102
20. Igbokwe I.O., and Anosa V.O. Response to anaemia in experimental Trypanosoma vivax infection of sheep. Journal of Comparative Pathology 100 (1989) 111-118
21. Kent S., Weinberg E.D., and Stuart-MacAdam P. Dietary and prophylactic iron supplements: helpful and harmful. Human Nature 1 (1990) 55-81
22. Lalonde R.G., and Holbein B.E. Role of iron in Trypanosoma cruzi infection of mice. Journal of Clinical Investigation 23 (1984) 470-476
23. Letendre E.D. The importance of iron in the pathogenesis of infection and neoplasia. Trends in Biochemical Sciences 12 (1985) 166-168
24. Lima M.F., and Villalta F. Trypanosoma cruzi trypomastigote clones differentially express a parasite adhesion molecule. Molecular and Biochemical Parasitology 33 (1989) 159-170
25. Loo V.G., and Lalonde R.G. Role of iron in intracellular growth of Trypanosoma cruzi. Infection and Immunity 45 (1984) 726-730
26. Marcondes M.C.G., Borelli P., Yoshida N., and Russo M. Acute Trypanosoma cruzi infection is associated with anemia, thrombocytopenia, leukopenia, and bone marrow hypoplasia: reversal by nifurtimox treatment. Microbes and Infection 2 (2000) 347-352
27. Miyamoto C.T., Gomes M.L., Marangon A.V., Araujo S.M., Bahia M.T., Lana M., and Toledo M.J. Trypanosoma cruzi: sensitivity of the polymerase chain reaction for detecting the parasite in the blood of mice infected with different clonal genotypes. Experimental Parasitology 112 (2006) 198-201
28. Murta S.M.F., Ropert C., Alves R.O., Gazzinelli R.T., and Romanha A.J. In vivo treatment with benznidazole enhances phagocytosis, parasite destruction and cytokine release by macrophages during infection with a drug-susceptible but not with a derived drug-resistant Trypanosoma cruzi population. Parasite Immunology 21 (1999) 535-544
29. + T-Cell expansion and promotes resistance to reinfection. Antimicrobial Agents and Chemotherapy 46 (2002) 3790-3796
30. Olivieri B.P., de Souza A.P., Cotta-de-Almeida V., de Castro S.L., and Araújo-Jorge T. Trypanosoma cruzi: alteration in the lymphoid compartments following interruption of infection by early acute benznidazole therapy in mice. Experimental Parasitology 114 (2006) 228-234
31. Pedrosa M.L., Silva M.E., Silva M.E., Silva M.E.C., Nicoli J.R., and Vieira E.C. The effect of iron deficiency and iron overload on the evolution of Chagas' disease produced by three strains of Trypanosoma cruzi in CFW mice. Comparative Biochemistry and Physiology 97 (1990) 235-243
32. Pedrosa M.L., Nicoli J.R., Silva M.E., Silva M.E., Silva M.E.C., Vieira L.Q., Bambirra E.A., and Vieira E.C. The effect of iron nutritional status on Trypanosoma cruzi infection in germfree and conventional mice. Comparative Biochemistry and Physiology 106 (1993) 813-821
33. Revelli S., Le Page C., Piaggio E., Wietzerbin J., and Bottasso O. Benznidazole, a drug employed in the treatment of Chagas' disease, down-regulates the synthesis of nitrite and cytokines by murine stimulated macrophages. Clinical and Experimental Immunology 118 (1999) 271-277
34. Ruiz R.C., Fernandes M., and Irulegui I. Observation of marked thrombcytopenia during the course of acute experimental Chagas' disease. Memórias do Instituto Oswaldo Cruz 84 (1989) 26
35. Santos F.R., Pena S.D.J., and Epplen J.T. Genetic and population study of a Y-linked tetranucleotide repeat DNA polymorphism with a simple non-isotopic technique. Human Genetics 90 (1993) 655-656
36. Santos C.D., Caldeira J.C., Toldo M.P., and Prado J.C. Trypanosoma cruzi: effects of repetitive stress during the development of experimental infection. Experimental Parasitology 110 (2005) 96-101
37. Santos C.D., Prado Jr. J.C., Toldo M.P.A., Levy A.M.A., Franci C.R., and Caldeira J.C. Trypanosoma cruzi: plasma corticosterone after repetitive stress during the acute phase of infection. Experimental Parasitology 117 (2007) 405-410
38. Silva L.H.P., and Nussenzweig V. Sobre uma cepa de Trypanosoma cruzi altamente virulenta para o camundongo branco. Folia Clinica et Biologica 20 (1953) 191-203
39. Srivastava P.J., Chandra S., Arif A.J., Singh C., and Panday V. Metal chelators/antioxidants: approaches to protect erythrocytic oxidative stress injury during Plasmodium berghei infection in Mastomys coucha. Pharmacology Research 40 (1999) 239-241
40. Turrens J.F. Oxidative stress and antioxidant defences: a target for the treatment of diseases caused by parasitic protozoa. Molecular Aspects of Medicine 25 (2004) 211-220
41. Viotti R., Vigliano C., Armenti H., and Segura E. Treatment of chronic Chagas disease with benznidazole: clinical and serological evolution of patients with long-term follow-up. American Heart Journal 127 (1994) 151-162
42. Weinberg E.D. Iron withholding: a defence against infection and neoplasia. Physiological Reviews 64 (1984) 65-102
43. WHO, 2005. Tropical Disease Research: Progress 2003-2004 Seventeenth Programme Report of the UNICEF/UNDP/World Bank/WHO. Special Programme for Research & Training in Tropical Diseases. Programme Report 17, World Health Organization, Geneva.
44. Wen J.J., Yachelini P.C., Sembaj A., Manzur R.E., and Garg N.J. Increased oxidative stress is correlated with mitochondrial dysfunction in chagasic patients. Free Radical Biology and Medicine 42 (2006) 270-276
45. Wincker P., Britto C., Pereira J.B., Cardoso M.A., Oelemann W., and Morel C.M. Use of a simplified polymerase chain reaction procedure to detect Trypanosoma cruzi in blood samples from chronic chagasic patients in a rural endemic area. American Journal of Tropical Medicine and Hygiene 51 (1994) 771-777